SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT |
SCHEDULE
OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT
|
|
Healthcare IT |
|
|
Medical Practice
Management |
|
|
Unallocated
Corporate
Expenses |
|
|
Total |
|
|
|
Year Ended December 31, 2023
($ in thousands) |
|
|
|
Healthcare IT |
|
|
Medical Practice
Management |
|
|
Unallocated
Corporate
Expenses |
|
|
Total |
|
Net revenue |
|
$ |
103,683 |
|
|
$ |
13,376 |
|
|
$ |
- |
|
|
$ |
117,059 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
60,319 |
|
|
|
10,498 |
|
|
|
- |
|
|
|
70,817 |
|
Selling and marketing |
|
|
9,614 |
|
|
|
36 |
|
|
|
- |
|
|
|
9,650 |
|
General and administrative |
|
|
10,992 |
|
|
|
1,854 |
|
|
|
8,618 |
|
|
|
21,464 |
|
Research and development |
|
|
4,736 |
|
|
|
- |
|
|
|
- |
|
|
|
4,736 |
|
Change
in contingent consideration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
14,046 |
|
|
|
356 |
|
|
|
- |
|
|
|
14,402 |
|
Goodwill impairment charges |
|
|
42,000 |
|
|
|
- |
|
|
|
- |
|
|
|
42,000 |
|
Loss on lease terminations, unoccupied lease charges and restructuring costs |
|
|
1,105 |
|
|
|
- |
|
|
|
- |
|
|
|
1,105 |
|
Total operating expenses |
|
|
142,812 |
|
|
|
12,744 |
|
|
|
8,618 |
|
|
|
164,174 |
|
Operating (loss) income |
|
$ |
(39,129 |
) |
|
$ |
632 |
|
|
$ |
(8,618 |
) |
|
$ |
(47,115 |
) |
|
|
Healthcare
IT |
|
|
Medical
Practice
Management |
|
|
Unallocated
Corporate
Expenses |
|
|
Total |
|
|
|
Year
Ended December 31, 2022 ($ in thousands) |
|
|
|
Healthcare
IT |
|
|
Medical
Practice
Management |
|
|
Unallocated
Corporate
Expenses |
|
|
Total |
|
Net
revenue |
|
$ |
125,276 |
|
|
$ |
13,550 |
|
|
$ |
- |
|
|
$ |
138,826 |
|
Operating
expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
operating costs |
|
|
73,702 |
|
|
|
10,732 |
|
|
|
- |
|
|
|
84,434 |
|
Selling
and marketing |
|
|
9,760 |
|
|
|
28 |
|
|
|
- |
|
|
|
9,788 |
|
General
and administrative |
|
|
12,558 |
|
|
|
1,802 |
|
|
|
9,460 |
|
|
|
23,820 |
|
Research
and development |
|
|
4,401 |
|
|
|
- |
|
|
|
- |
|
|
|
4,401 |
|
Change
in contingent consideration |
|
|
(3,090 |
) |
|
|
- |
|
|
|
- |
|
|
|
(3,090 |
) |
Depreciation
and amortization |
|
|
11,368 |
|
|
|
357 |
|
|
|
- |
|
|
|
11,725 |
|
Net
loss on lease terminations and unoccupied lease charges |
|
|
1,138 |
|
|
|
- |
|
|
|
- |
|
|
|
1,138 |
|
Loss on lease terminations, unoccupied lease charges and restructuring costs |
|
|
1,138 |
|
|
|
- |
|
|
|
- |
|
|
|
1,138 |
|
Total
operating expenses |
|
|
109,837 |
|
|
|
12,919 |
|
|
|
9,460 |
|
|
|
132,216 |
|
Operating
income (loss) |
|
$ |
15,439 |
|
|
$ |
631 |
|
|
$ |
(9,460 |
) |
|
$ |
6,610 |
|
|